Xunfei Healthcare Technology Co (HKSE:02506) ROCE %: 1.89% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02506 Xunfei Healthcare Technology Co Ltd HKSE:02506
6 GF Score
Price HK$64.80
! 3 Warning Signs
View Full Analysis

What is Xunfei Healthcare Technology Co ROCE %?

Xunfei Healthcare Technology Co HKSE:02506 -0.61% 6 ROCE % is 1.89% as of Dec. 2025. GuruFocus rates HKSE:02506 with a GF Score™ of 6/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Xunfei Healthcare Technology Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 1.89%.


Xunfei Healthcare Technology Co  (HKSE:02506) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Xunfei Healthcare Technology Co ROCE % Related Terms


Xunfei Healthcare Technology Co ROCE % Historical Data

* Premium members only.

The historical data trend for Xunfei Healthcare Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xunfei Healthcare Technology Co ROCE % Chart

Xunfei Healthcare Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
-20.54 -48.55 -37.08 -19.86 -7.77

Xunfei Healthcare Technology Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial -20.90 -61.09 -1.19 -17.10 1.89
HKSE:02506
6GF Score
Xunfei Healthcare Technology Co Ltd HKSE:02506
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xunfei Healthcare Technology Co ROCE % Calculation

Xunfei Healthcare Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-93.399/( ( (2231.367 - 1067.981) + (2554.561 - 1313.947) )/ 2 )
=-93.399/( (1163.386+1240.614)/ 2 )
=-93.399/1202
=-7.77 %

Xunfei Healthcare Technology Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=23.796/( ( (2538.909 - 1265.148) + (2554.561 - 1313.947) )/ 2 )
=23.796/( ( 1273.761 + 1240.614 )/ 2 )
=23.796/1257.1875
=1.89 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.89% mean?
Xunfei Healthcare Technology Co (HKSE:02506) has a ROCE % of 1.89% as of Dec. 2025.
Is Xunfei Healthcare Technology Co's ROCE % too high?
Xunfei Healthcare Technology Co's current ROCE % is 1.89%. The Healthcare Providers & Services industry median ROCE % is 6.63. Xunfei Healthcare Technology Co's value of 1.89% is 71.5% below this industry median. Overall, Xunfei Healthcare Technology Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Xunfei Healthcare Technology Co's ROCE % compare to VEEV and BTSG?
Xunfei Healthcare Technology Co's ROCE % of 1.89% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.63. Xunfei Healthcare Technology Co's value of 1.89% is 71.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.63, based on 643 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xunfei Healthcare Technology Co's current ROCE % of 1.89% is 71.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xunfei Healthcare Technology Co's current ROCE % is 1.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xunfei Healthcare Technology Co stock overvalued right now?
Xunfei Healthcare Technology Co (HKSE:02506) has a current ROCE % of 1.89%. The current ROCE % is 1.89% and 71.5% below the Healthcare Providers & Services industry median of 6.63. Xunfei Healthcare Technology Co's overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Xunfei Healthcare Technology Co (HKSE:02506), the current ROCE % is 1.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xunfei Healthcare Technology Co Business Description

Address No. 666 Science and Innovation Road, High-tech Zone, 4 to 5/F (North Area), No.1 Building, Anhui Province, iFLYTEK AI Research and Development Production Bas, Chengxiqiao Community Services Center, Hefei, CHN
Xunfei Healthcare Technology Co Ltd is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment, and treatment effect evaluation, to post-discharge management and chronic disease management. The company has independently developed AI technologies that underpin its products and solutions including Smart Healthcare, Smart Hospital, Smart Hardware, Smart Medical Insurance, and Smart Film Union.
6GF Score

Get the complete analysis for HKSE:02506

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$64.80
Price